Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis
- PMID: 33221457
- PMCID: PMC7521884
- DOI: 10.1016/j.phymed.2020.153337
Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis
Abstract
Background: Throughout the 5000-year history of China, more than 300 epidemics were recorded. Traditional Chinese herbal medicine (TCM) has been used effectively to combat each of these epidemics' infections, and saved many lives. To date, there are hundreds of herbal TCM formulae developed for the purpose of prevention and treatment during epidemic infections. When COVID-19 ravaged the Wuhan district in China in early January 2020, without a deep understanding about the nature of COVID-19, patients admitted to the TCM Hospital in Wuhan were immediately treated with TCM and reported later with >90% efficacy.
Approach: We conducted conduct a systematic survey of various TCM herbal preparations used in Wuhan and to review their efficacy, according to the published clinical data; and, secondly, to find the most popular herbs used in these preparations and look into the opportunity of future research in the isolation and identification of bioactive natural products for fighting COVID-19.
Results: Although bioactive natural products in these herbal preparations may have direct antiviral activities, TCM employed for fighting epidemic infections was primarily based on the TCM theory of restoring the balance of the human immune system, thereby defeating the viral infection indirectly. In addition, certain TCM teachings relevant to the meridian system deserve better attention. For instance, many TCM herbal preparations target the lung meridian, which connects the lung and large intestine. This interconnection between the lung, including the upper respiratory system, and the intestine, may explain why certain TCM formulae showed excellent relief of lung congestion and diarrhea, two characteristics of COVID-19 infection.
Conclusion: There is good reason for us to learn from ancient wisdom and accumulated clinical experience, in combination with cutting edge science and technologies, to fight with the devastating COVID-19 pandemic now and emerging new coronaviruses in the future.
Keywords: Medicinal herb; Phytotherapy; SARS-CoV-2; Viral infection.
Copyright © 2020 Elsevier GmbH. All rights reserved.
Conflict of interest statement
We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
Similar articles
-
Ayurvedic and Chinese Herbs against Coronaviruses.Curr Pharm Des. 2024;30(21):1681-1698. doi: 10.2174/0113816128269864231112094917. Curr Pharm Des. 2024. PMID: 38685809 Review.
-
Traditional Chinese Medicine as a complementary therapy in combat with COVID-19-A review of evidence-based research and clinical practice.J Adv Nurs. 2021 Apr;77(4):1635-1644. doi: 10.1111/jan.14673. Epub 2020 Nov 29. J Adv Nurs. 2021. PMID: 33174654
-
Traditional Chinese Medicine as the Preventive and Therapeutic Remedy for COVID-19.Curr Med Chem. 2024;31(21):3118-3131. doi: 10.2174/0929867330666230331084126. Curr Med Chem. 2024. PMID: 36999715 Review.
-
[Medicinal properties and compatibility application of aromatic traditional Chinese medicine monomer components based on action of volatile components against viral pneumonia].Zhongguo Zhong Yao Za Zhi. 2025 Apr;50(8):2013-2021. doi: 10.19540/j.cnki.cjcmm.20241224.401. Zhongguo Zhong Yao Za Zhi. 2025. PMID: 40461214 Chinese.
-
Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.J Ethnopharmacol. 2021 May 10;271:113854. doi: 10.1016/j.jep.2021.113854. Epub 2021 Jan 26. J Ethnopharmacol. 2021. PMID: 33513419 Free PMC article.
Cited by
-
Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses.Pathogens. 2021 May 7;10(5):565. doi: 10.3390/pathogens10050565. Pathogens. 2021. PMID: 34066983 Free PMC article. Review.
-
Coptisine Inhibits Influenza Virus Replication by Upregulating p21.Molecules. 2023 Jul 14;28(14):5398. doi: 10.3390/molecules28145398. Molecules. 2023. PMID: 37513270 Free PMC article.
-
The efficacy and safety of combined chinese herbal medicine and western medicine therapy for COVID-19: a systematic review and meta-analysis.Chin Med. 2022 Jun 21;17(1):77. doi: 10.1186/s13020-022-00600-z. Chin Med. 2022. PMID: 35729581 Free PMC article. Review.
-
Combinational study with network pharmacology, molecular docking and preliminary experiments on exploring common mechanisms underlying the effects of weijing decoction on various pulmonary diseases.Heliyon. 2023 Apr 20;9(5):e15631. doi: 10.1016/j.heliyon.2023.e15631. eCollection 2023 May. Heliyon. 2023. PMID: 37153415 Free PMC article.
-
Gut microbiota in COVID-19: new insights from inside.Gut Microbes. 2023 Jan-Dec;15(1):2201157. doi: 10.1080/19490976.2023.2201157. Gut Microbes. 2023. PMID: 37078497 Free PMC article.
References
-
- Attele A.S., Wu J.A., Yuan C.S. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol. 1999;58:1685–1693. - PubMed
-
- Bai M., Zheng CJ., Cai Y. The chemical constituents and antibacterial activities of Scutellaria luzonica Rolfe var. J Hainan Normal Univ. 2018;31:143–146.
-
- Beigel J.H., Tomashek K.M., Dodd L.E. Remdesivir for the treatment of Covid-19 - Final report. N Engl J Med. 2020 NEJMoa2007764 [published online ahead of print] - PubMed
-
- Calixto J.B., Campos M.M., Otuki M.F., Santos A.R. Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med. 2004;70:93–103. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous